Suchergebnisse - "Samant, Charudatt"

PubPharm (5)

1

Inhibition of SGK1 potentiates the anticancer activity of PI3K inhibitor in NSCLC cells through modulation of mTORC1, p‑ERK and β‑catenin signaling

enthalten in: Biomedical reports | 2023

von Kale, R. | Samant, C. | Bokare, A. | +3

2

PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways

enthalten in: Biochemistry and biophysics reports | 2023

von Samant, C. | Kale, R. | Bokare, A. | +3

3

Dual PI3Kδγ inhibition demonstrates potent anticancer effects in diffuse large B-cell lymphoma models : Discovery and preclinical characterization of LL-00084282

enthalten in: Biochemical and biophysical research communications | 2022

von Verma, M. | Samant, C. | Kale, R. | +28

4

Discovery and pre-clinical characterization of a selective PI3Kδ inhibitor, LL-00071210 in rheumatoid arthritis

enthalten in: European journal of pharmacology | 2022

von Kanoje, V. | Pandey, D. | Wagh, A. | +34

5

Discovery of a Potent and Selective PI3Kδ Inhibitor (S)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4H-quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer Models

enthalten in: Journal of medicinal chemistry | 2020

von Shukla, M. | Patra, S. | Verma, M. | +53

1
[1]